Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies

Volume 19, Issue 3, December 2023 .

Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Agnes Mwakingwe-OmariNicolas LecrenierAbdi NaficyDesmond CurranInga Posiunienea Clinical Sciences, GSK, Rockville, MD, USAb Medical Affairs Department, GSK, Wavre, Belgiumc Evidence and Outcome Department, GSK, Wavre, Belgium Source Type: research